If they deny your prior authorization, you face the option of filing an appeal meaning even more time and work
K.WagnerN
Now, two new late-phase clinical trials, sponsored by Eli Lilly and Company, suggest that transitioning from high dose injectable weight loss medications to either a daily pill or a lower maintenance dose can help people living with obesity to keep off most of the weight they have already lost The results of the ATTAIN-MAINTAIN and SURMOUNT-MAINTAIN trials were presented at the European Congress on Obesity and published in Previous research suggests that 1 year after stopping weight loss medication, people may regain, on average, 60% of their lost weight
FDA Wegovy (2021, 2024), STEP 1 NEJM (2021), STEP 5 NEJM (2022), Wegovy FDA (2023)
Because your appetite may be reduced and some people may drink less than usual, staying hydrated on GLP-1 isn't just a recommendationstaying hydrated is an important part of supporting your overall health while your body adjusts to treatment
While today's approval is an exciting development, individuals will not be able to access oral Wegovy immediately